Zynerba Pharmaceuticals Inc (ZYNE.OQ)
ZYNE.OQ on NASDAQ Stock Exchange Global Market
3.89USD
4:25pm GMT
3.89USD
4:25pm GMT
Change (% chg)
$-0.03 (-0.77%)
$-0.03 (-0.77%)
Prev Close
$3.92
$3.92
Open
$3.94
$3.94
Day's High
$3.95
$3.95
Day's Low
$3.82
$3.82
Volume
19,814
19,814
Avg. Vol
80,672
80,672
52-wk High
$12.98
$12.98
52-wk Low
$2.76
$2.76
About
Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet needs. Its development pipeline includes two product candidates: ZYN002 and ZYN001. ZYN002 is a synthetic cannabidiol (CBD), which... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $128.07 |
| Shares Outstanding(Mil.): | 13.26 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ZYNE.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.71 | 33.71 |
| EPS (TTM): | -2.62 | -- | -- |
| ROI: | -55.80 | 8.99 | 14.48 |
| ROE: | -55.80 | 10.13 | 15.99 |
Estimates